KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Share-based Compensation (2017 - 2025)

Guardant Health's Share-based Compensation history spans 9 years, with the latest figure at $43.2 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 18.76% year-over-year to $43.2 million; the TTM value through Dec 2025 reached $166.2 million, up 18.38%, while the annual FY2025 figure was $166.2 million, 18.38% up from the prior year.
  • Share-based Compensation for Q4 2025 was $43.2 million at Guardant Health, up from $42.8 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $55.1 million in Q1 2021 and bottomed at $20.6 million in Q3 2022.
  • The 5-year median for Share-based Compensation is $27.1 million (2024), against an average of $32.2 million.
  • The largest annual shift saw Share-based Compensation skyrocketed 768.87% in 2021 before it crashed 54.97% in 2022.
  • A 5-year view of Share-based Compensation shows it stood at $26.9 million in 2021, then fell by 11.74% to $23.7 million in 2022, then grew by 2.6% to $24.3 million in 2023, then soared by 49.53% to $36.4 million in 2024, then grew by 18.76% to $43.2 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Share-based Compensation are $43.2 million (Q4 2025), $42.8 million (Q3 2025), and $42.5 million (Q2 2025).